Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy-Reference-Cited by-同舟云学术

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

Published:2021-12 Issue: Volume:34 Page:70-78
ISSN:2666-1683
Container-title:European Urology Open Science
language:en
Short-container-title:European Urology Open Science

Author:

Autio Karen A.^ORCID,Antonarakis Emmanuel S.,Mayer Tina M.,Shevrin Daniel H.,Stein Mark N.,Vaishampayan Ulka N.,Morris Michael J.,Slovin Susan F.,Heath Elisabeth I.,Tagawa Scott T.,Rathkopf Dana E.,Milowsky Matthew I.,Harrison Michael R.,Beer Tomasz M.,Balar Arjun V.,Armstrong Andrew J.,George Daniel J.,Paller Channing J.,Apollo Arlyn,Danila Daniel C.,Graff Julie N.,Nordquist Luke,Dayan Cohn Erica S.,Tse Kin,Schreiber Nicole A.,Heller Glenn,Scher Howard I.

Publisher

Elsevier BV

Subject

Urology

Reference31 articles.

1. Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study;Fizazi;Lancet Oncol,2012

2. Abiraterone in metastatic prostate cancer without previous chemotherapy;Ryan;N Engl J Med,2013

3. Drug development for noncastrate prostate cancer in a changed therapeutic landscape;Teo;Nat Rev Clin Oncol,2018

4. Efficacy analysis of a phase III study of androgen deprivation therapy (ADT) +/- docetaxel (D) for men with biochemical relapse (BCR) after prostatectomy;Morris;J Clin Oncol,2015

5. The molecular taxonomy of primary prostate cancer;Abeshouse;Cell,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysis;Prostate Cancer and Prostatic Diseases;2024-09-13

2. Cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: a systematic review, meta-analysis, and network meta-analysis;Prostate Cancer and Prostatic Diseases;2024-09-05

3. Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic Review;European Urology;2024-09

4. Androgen deprivation therapy exacerbates Alzheimer’s-associated cognitive decline via increased brain immune cell infiltration;Science Advances;2024-06-21

5. Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial;European Urology Oncology;2024-05